Skip to main content

Adverse Drug Event Reporting The Roles of Consumers and Health-Care Professionals: Workshop Summary (2007) / Chapter Skim
Currently Skimming:

References
Pages 48-52

The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.


From page 48...
... project. Journal of the American Medical Association 293:2131–2140.
Read the entire page →
From page 49...
... Journal of the American Medical Association 286:831–833. Greenhill LL, Vitiello B, Abikoff H, Levine J, March JS, Riddle MA, Capasso L, Cooper TB, Davies M, Fisher P, Findling RL, Fried J, Labellarte MJ, McCracken JT, McMahon D, Robinson J, Skrobala A, Scahill L, Varipatis E, Walkup JT, Zito JM.
Read the entire page →
From page 50...
... Journal of the American Medical Association 294(22)
Read the entire page →
From page 51...
... Journal of the American Medical Association 284:3036–3039. Spina JR, Glassman PA, Belperio P, Cader R, Asch S
Read the entire page →

Key Terms

  • drug safety
  • prescription drug
  • drug event
  • drug interaction
  • drug events

  • suspected adverse
  • pharmacists association
  • data interchange
  • clinical data
  • postmarketing surveillance

  • event reporting
  • adverse events
  • van bergen
  • american pharmacists
  • community pharmacy

  • adverse event
  • draft guidance
  • preventable drug
  • drug experiences
  • automated drug

  • drug related
  • drug information
  • drug effects
  • improve drug
  • drug alerts

  • modern information
  • error reporting
  • ncc merp
  • postmarket surveillance
  • clinical trials


    • This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
    More information on Chapter Skim is available.